Revelation Biosciences, Inc. (NASDAQ:REVBW – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 3,307 shares, an increase of 184.6% from the May 14th total of 1,162 shares. Based on an average daily volume of 80,422 shares, the days-to-cover ratio is presently 0.0 days.
Revelation Biosciences Stock Down 30.2%
Shares of REVBW stock traded down $0.00 during midday trading on Friday, reaching $0.01. 26,181 shares of the company were exchanged, compared to its average volume of 81,885. Revelation Biosciences has a 12 month low of $0.01 and a 12 month high of $0.04. The company’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.01.
Revelation Biosciences Company Profile
Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.
The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.
Read More
- Five stocks we like better than Revelation Biosciences
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
